These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 26709517)

  • 61. mTORC1 signaling is crucial for regulatory T cells to suppress macrophage-mediated inflammatory response after acute myocardial infarction.
    Yang K; Zhang Y; Xu C; Li X; Li D
    Immunol Cell Biol; 2016 Mar; 94(3):274-84. PubMed ID: 26437770
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CXADR-like membrane protein protects against heart injury by preventing excessive pyroptosis after myocardial infarction.
    Han X; Zhao ZA; Yan S; Lei W; Wu H; Lu XA; Chen Y; Li J; Wang Y; Yu M; Wang Y; Zheng Y; Wang H; Shen Z; Hu S
    J Cell Mol Med; 2020 Dec; 24(23):13775-13788. PubMed ID: 33084169
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intramyocardial administration of chimeric ephrinA1-Fc promotes tissue salvage following myocardial infarction in mice.
    Dries JL; Kent SD; Virag JA
    J Physiol; 2011 Apr; 589(Pt 7):1725-40. PubMed ID: 21282286
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Benfotiamine improves functional recovery of the infarcted heart via activation of pro-survival G6PD/Akt signaling pathway and modulation of neurohormonal response.
    Katare R; Caporali A; Emanueli C; Madeddu P
    J Mol Cell Cardiol; 2010 Oct; 49(4):625-38. PubMed ID: 20542491
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pretreatment of carprofen impaired initiation of inflammatory- and overlapping resolution response and promoted cardiorenal syndrome in heart failure.
    Krishnan V; Booker D; Cunningham G; Jadapalli JK; Kain V; Pullen AB; Halade GV
    Life Sci; 2019 Feb; 218():224-232. PubMed ID: 30597172
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cardiac (myo)fibroblast: Novel strategies for its targeting following myocardial infarction.
    Daskalopoulos EP; Hermans KC; Blankesteijn WM
    Curr Pharm Des; 2014; 20(12):1987-2002. PubMed ID: 23844732
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Identification of murine phosphodiesterase 5A isoforms and their functional characterization in HL-1 cardiac cell line.
    Campolo F; Zevini A; Cardarelli S; Monaco L; Barbagallo F; Pellegrini M; Cornacchione M; Di Grazia A; De Arcangelis V; Gianfrilli D; Giorgi M; Lenzi A; Isidori AM; Naro F
    J Cell Physiol; 2018 Jan; 233(1):325-337. PubMed ID: 28247930
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Subacute treatment of carprofen facilitate splenocardiac resolution deficit in cardiac injury.
    Halade GV; Kain V; Wright GM; Jadapalli JK
    J Leukoc Biol; 2018 Dec; 104(6):1173-1186. PubMed ID: 30145840
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Lactic acid inhibits iNKT cell functions via a phosphodiesterase-5 dependent pathway.
    Wang L; Wu Q; Liu J; Zhang H; Bai L
    Biochem Biophys Res Commun; 2021 Apr; 547():9-14. PubMed ID: 33588236
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cardiac oxidative stress and inflammatory cytokines response after myocardial infarction.
    Neri M; Fineschi V; Di Paolo M; Pomara C; Riezzo I; Turillazzi E; Cerretani D
    Curr Vasc Pharmacol; 2015; 13(1):26-36. PubMed ID: 23628007
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Phosphodiesterase 5A regulates the vomeronasal pump in mice.
    Lippner DS; Xu J; Ma S; Reisert J; Zhao H
    Genesis; 2024 Jun; 62(3):e23603. PubMed ID: 38738564
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comprehensive targeted and non-targeted lipidomics analyses in failing and non-failing heart.
    Halade GV; Dorbane A; Ingle KA; Kain V; Schmitter JM; Rhourri-Frih B
    Anal Bioanal Chem; 2018 Mar; 410(7):1965-1976. PubMed ID: 29411084
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition.
    Panahi M; Papanikolaou A; Torabi A; Zhang JG; Khan H; Vazir A; Hasham MG; Cleland JGF; Rosenthal NA; Harding SE; Sattler S
    Cardiovasc Res; 2018 Sep; 114(11):1445-1461. PubMed ID: 30010800
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Translational overview of cytokine inhibition in acute myocardial infarction and chronic heart failure.
    Hartman MHT; Groot HE; Leach IM; Karper JC; van der Harst P
    Trends Cardiovasc Med; 2018 Aug; 28(6):369-379. PubMed ID: 29519701
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Metabolomics study of the effect of smoking and high-fat diet on metabolic responses and related mechanism following myocardial infarction in mice.
    Zhao Z; Zhang Y; Liu L; Chen Y; Wang D; Jin X; Shen C
    Life Sci; 2020 Dec; 263():118570. PubMed ID: 33058917
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Spatiotemporal dynamics of macrophage heterogeneity and a potential function of Trem2
    Jung SH; Hwang BH; Shin S; Park EH; Park SH; Kim CW; Kim E; Choo E; Choi IJ; Swirski FK; Chang K; Chung YJ
    Nat Commun; 2022 Aug; 13(1):4580. PubMed ID: 35933399
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.
    Huang S; Frangogiannis NG
    Br J Pharmacol; 2018 May; 175(9):1377-1400. PubMed ID: 29394499
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Heart Failure Post-Myocardial Infarction Promotes Mammary Tumor Growth Through the NGF-TRKA Pathway.
    Tani T; Oikawa M; Misaka T; Ishida T; Takeishi Y
    JACC CardioOncol; 2024 Feb; 6(1):55-66. PubMed ID: 38510296
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Matricellular Protein Cilp1 Promotes Myocardial Fibrosis in Response to Myocardial Infarction.
    Zhang QJ; He Y; Li Y; Shen H; Lin L; Zhu M; Wang Z; Luo X; Hill JA; Cao D; Luo RL; Zou R; McAnally J; Liao J; Bajona P; Zang QS; Yu Y; Liu ZP
    Circ Res; 2021 Nov; 129(11):1021-1035. PubMed ID: 34610755
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Targeting necroptosis as therapeutic potential in chronic myocardial infarction.
    Piamsiri C; Maneechote C; Siri-Angkul N; Chattipakorn SC; Chattipakorn N
    J Biomed Sci; 2021 Apr; 28(1):25. PubMed ID: 33836761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.